Hutch News

Hutch News

Stories tagged 'metastasis'

Good News at Fred Hutch

Celebrating faculty and staff achievements

March 31, 2017

Dr. Philip Greenberg elected to serve on AACR board of directors; five researchers receive awards to explore immunotherapy single-cell RNA sequencing.

View story >


Living with stage 4

In a culture focused on survivorship, those with metastatic breast cancer who will be in treatment for the rest of their lives can feel isolated and misunderstood

Oct. 13, 2016 | By Diane Mapes / Fred Hutch News Service

In a culture focused on survivorship, those with metastatic breast cancer who will be in treatment for the rest of their lives can feel isolated and misunderstood.

View story >


Inherited mutations tied to advanced prostate cancer

Genetic screening could help men with prostate cancer find better treatments — and alert family members to their own cancer risk

July 6, 2016 | By Sabrina Richards / Fred Hutch News Service

A new study shows men with metastatic prostate cancer are five times likelier to harbor inherited mutations in BRCA1/2 and other DNA-repair genes than the general population, irrespective of age or family history of prostate cancer.

View story >


The science of cancer spread

The how and why of metastasis — and what it might take to stop it

April 28, 2016 | By Rachel Tompa / Fred Hutch News Service

Metastasis, or cancer spread, is complex and still largely mysterious. What do researchers know -- and what do they still need to know to stop metastasis?

View story >


‘I feel like this is the year’

New strides in metastatic breast cancer research and advocacy give patients, scientists hope

April 27, 2016 | By Diane Mapes / Fred Hutch News Service

Metastatic breast cancer kills around 40,000 women (and men) a year, but a handful of MBC patients who visited Fred Hutch recently say they're more encouraged than ever. Find out why.

View story >


Is metastatic prostate cancer tailor-made for precision oncology?

New study shows a single biopsy could provide enough molecular information to guide individualized therapy for prostate cancer patients

Feb. 29, 2016 | By Sabrina Richards / Fred Hutch News Service

A new study from scientists at Fred Hutchinson Cancer Research Center and the University of Washington suggests metastatic prostate cancer may present just the pair of characteristics needed for precision oncology: Metastases from different patients varied widely in their genetic characteristics, and metastases within a single patient were remarkably similar.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.